Business trending topics
1,330 results
Bridgewater, MA -- (SBWIRE) -- 05/20/2013 -- The online StockConsultant latest screen has found a biotech company that produces drugs for central nervous system disorders ACADIA Pharmaceuticals Inc. (NASDAQ …SBWire · 5/20/2013
In-depth coverage
ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the completion of an underwritten public ...Reuters · 5/20/2013
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance …StreetInsider · 5/14/2013
The Motley Fool
symbol=BYD ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock is at $12.07, up 51.44 percent from its previous close of $7.97. The stock opened the session at $11.11 and touched its highest price point at $12.24, which is also its 52 weeks highest …Marketwatch · 4/11/2013
Its shares gained +55.45% so far in 2013. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock sold in a range of $13.40 to $14.75 before ending +6.63% higher to settle at $14.15 as was added to NASDAQ …therem.org · 5/21/2013
SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD ) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock, offered at a price to the public of $12.50 per share. The gross ...The Motley Fool · 5/15/2013
Find out if (ACAD) is in Cramer's Portfolio. The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Biotechnology industry. The net ...TheStreet.com · 3/28/2013
Baker Brothers bought 2mm shares, which is 25% of the 8mm shares issued (and if the greenshoe is exercised it would obv be a lower %). This is bullish, but let's not read too much into it- they need to buy into the deal to not be diluted down ...Yahoo! Finance · 5/20/2013
stock=PDLI&SubId=AW ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a biopharmaceutical company that focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders closed up in its …markets.financialcontent.com · 5/14/2013
Hence I am holding this CAP leader and believe that it is the absolute safest developmental biotechnology stock in the market. Despite Large Gains, This Stock Is Still Surprisingly Cheap Rite Aid (NYSE: RAD) is without question my favorite value ...beta.fool.com · 5/21/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback